AI Article Synopsis
- The study investigates Elabela as a potential laboratory marker for predicting placenta previa and placenta accreta, two serious obstetric conditions that currently lack biochemical diagnostic tools.
- Conducted between 2020 and 2022 at two tertiary centers, the research analyzed Elabela levels in groups with plancental anomalies, finding significant differences in Elabela levels among control, previa, and accreta groups.
- Results indicated a promising cut-off value for Elabela in diagnosing both conditions, with sensitivity and specificity showing potential for Elabela to be used as a biochemical marker, encouraging further research in this area.
Article Abstract
Introduction: Placenta previa and Placenta Accreta Spectrum are life-threatening obstetric conditions that are challenging to diagnose accurately. Currently, there is no biochemical parameter available for their diagnosis. The aim of our study is to investigate the potential of Elabela as a laboratory marker that could predict placenta previa and placenta accreta, both of which can lead to severe, life-threatening complications for the mother.
Methods: In this study, which was conducted prospectively in two tertiary centers between 2020 and 2022, Elabela levels were examined in patient groups with placental insertion and invasion anomalies. SPSS program was used for comparative statistical analysis between groups.
Results: Of the 67 analyzed patients, 32 were in the control group, 12 were in the previa group, and 23 were in the accreta group. There was no statistically significant difference between the groups regarding age, BMI, number of curettages, presence of previous cesarean section, and smoking status. The Elabela level was measured at 135.6 ± 72.1 in the control group, 988.3 ± 925.5 in the previa group, and 376 ± 364.6 in the accreta group, with a statistically significant difference between the groups. The cut-off value of Elabela levels in the previa group was determined to be 304, with a sensitivity of 83.30 % and a specificity of 83.60 % (AUC = 0.909). In the accreta group, the cut-off value was 195.5, with a sensitivity of 60.90 % and a specificity of 61.40 % (AUC = 0.658).
Discussion: By showing that the prediction of placenta previa and placenta acreata can be made with a biochemical parameter in our study, young researchers will focus more on this subject and thus make many contributions to science.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.placenta.2024.12.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Takayasu's arteritis in pregnancy: A case report and literature review.
Int J Gynaecol Obstet
December 2024
Department of Obstetrics and Gynaecology, Kathmandu Medical College Public Limited, Kathmandu, Nepal.
Article Synopsis
- * A case report describes a 23-year-old pregnant woman with TA who experienced fainting and arm pulselessness; she was diagnosed early, enabling timely treatment and comprehensive care.
- * Despite developing gestational hypertension and other complications, a successful emergency cesarean section at 36 weeks resulted in a healthy recovery for both mother and child, highlighting the importance of early diagnosis and collaborative medical care.
Maternal Morbidity and Medically Assisted Reproduction Treatment Types.
Obstet Gynecol
December 2024
Centre for Longitudinal Studies, Social Research Institute, University College London, London, United Kingdom; Population Science, Huntsman Cancer Institute, the Department of Family and Consumer Studies, the Department of Obstetrics and Gynecology, and the Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City; Max Planck Institute for Demographic Research, Rostock, Germany; the Helsinki Institute for Demography and Population Health, University of Helsinki, Helsinki, Finland; and the Max Planck - University of Helsinki Center for Social Inequalities in Population Health, Rostock, Germany and Helsinki, Finland.
Article Synopsis
- The study aims to analyze the risk of maternal morbidity based on how pregnancies were achieved, focusing on various methods of medically assisted reproduction like fertility drugs, IUI, and ART.
- Data from Utah's birth certificates (2009-2017) showed that 4.8% of pregnancies were from assisted reproduction, with maternal morbidity defined by complications like blood transfusions and ICU admissions.
- Results indicated higher maternal morbidity risks for those using assisted reproduction, particularly with ART and autologous oocytes, although these risks decreased when controlling for factors like multiple pregnancies and existing health issues.
Association between obesity in women with multiple gestations and adverse obstetric outcomes: a study of an American population database with over 136,000 unique deliveries.
Arch Gynecol Obstet
December 2024
Obstetrics and Gynecology, McGill University Health Centre, Montreal, Canada.
Purpose: The purpose of this study is to compare obese and non-obese women with multiple pregnancies to determine the effects on pregnancy, delivery, and neonatal outcomes.
Methods: We conducted a retrospective population-based study utilizing data collected between 2004 and 2014 inclusively, from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample. A total of 137,303 multiple pregnancies were analyzed; 130,542 (95%) were non-obese, while 6761 (5%) were obese.
Abnormal microRNA expression profile at early stages of gestation in pregnancies destined to develop placenta previa.
Front Med (Lausanne)
December 2024
Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czechia.
Article Synopsis
- Placenta previa is a condition where the placenta implants abnormally in the lower uterus, leading to serious risks for both the mother and fetus, including hemorrhage and stillbirth.
- This study focused on analyzing microRNA expression in the blood during the first trimester of pregnancies that later developed placenta previa, comparing them to normal pregnancies.
- The results showed that several microRNAs were downregulated in those pregnancies, with a combination of seven specific microRNAs accurately distinguishing between healthy and placenta previa pregnancies early on.
Risk Factors of Marginal Cord Insertion in Singleton Pregnancies: A Systematic Review and Meta-Analysis.
J Clin Med
December 2024
Third Department of Obstetrics and Gynecology, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Agiou Dimitriou, 54124 Thessaloniki, Greece.
Article Synopsis
- Marginal cord insertion (MCI) is considered a pathological condition that requires early diagnosis and understanding its risk factors can improve prenatal care.
- A meta-analysis of 18 studies revealed that the prevalence of MCI in singleton pregnancies is 5.71%, identifying significant risk factors such as assisted reproductive technology, chronic hypertension, placenta previa, and nulliparity.
- The analysis followed strict guidelines and methods to ensure quality, indicating that factors like smoking, maternal age, and prior Cesarean sections were not significantly associated with MCI.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!